CIMS Global

Ensuring Safety in Clinical Trials: Key Takeaways from FDA Guidelines The FDA has recently reinforced its commitment to the safety of participants in clinical trials through comprehensive guidelines on safety monitoring. Here are some critical points to consider: Proactive Risk Management: Identifying potential risks early and developing mitigation strategies is paramount. This includes rigorous pre-trial assessments and continuous monitoring throughout the trial. Data Monitoring Committees (DMCs): Establishing independent DMCs ensures unbiased safety evaluations. These committees play a crucial role in reviewing adverse events and can recommend modifications or even halting the trial if necessary. Real-Time Reporting: Utilizing advanced technology for real-time data collection and analysis allows for prompt identification and response to safety concerns, ensuring participant well-being. Participant Communication: Clear and transparent communication with trial participants about potential risks and ongoing safety measures fosters trust and compliance. Learn how DMC-HUB powered by DDM™ can help you align with new FDA safety requirements. https://lnkd.in/dynjz5Fs Read the entire report here: https://lnkd.in/dA7UMcER #ClinicalTrials #SafetyMonitoring #FDA #MedicalResearch #HealthcareInnovation

#DataMonitoringCommittees #FDA #ClinicalTrials

Happy Friday from the new CIMS Office! We're thrilled to share that we've upgraded to a larger space, providing us with more room to foster collaboration and accelerate innovation. #NewBeginnings #InnovationHub

💡At CIMS, we believe that every team member, regardless of their role or tenure, holds the potential to drive our next big breakthrough. Whether it's a fresh perspective from a new hire or a seasoned insight from a long-time colleague, diversity of thought is our greatest asset. #Innovation #Teamwork

Good experience at PharmaSUG 2024 and new connections and friends. See you next year! #PharmaSUG2024

Today, on World Clinical Trials Day, we at CIMS Global proudly acknowledge the incredible contributions of researchers, healthcare professionals, sites and participants who drive innovation and progress in medical science. #CTD2024 #clinicaltrials #clinicaltrialsday

The Power of Data in Medical Innovation The recent four-year study on Sotyktu (deucravacitinib) for moderate-to-severe plaque psoriasis showcases the transformative potential of comprehensive data analysis. Consistent safety and durable response rates underline its efficacy, highlighting the importance of long-term data in advancing treatment options. At CIMS, we leverage revolutionary tools to harness robust data, driving forward innovations that enhance patient care and outcomes. Let's continue to unlock the full potential of data for a healthier future. #DataDriven #MedicalInnovation #CIMS #HealthcareTransformation #clinicaltrials

We are excited to feature Xiaoliu Xu, our Clinical Data Scientist II, as our CIMS Spotlight of the month! She is a highly valuable member of our team and we are very grateful to have her. Xiaoliu (Sue) Xu

We want to hear from you!

🌍 This Earth Day, Let's Embrace Paper Saving in Clinical Trials with eBinder! https://lnkd.in/e6fX2cEr eBinder revolutionizes the way clinical trials are conducted by digitizing the entire process, from documentation to data processing. Here's why eBinder is a game-changer: 🌱 Paperless Operations: Say goodbye to mountains of paperwork! With eBinder, we eliminate the need for paper-based documents, reducing waste and transcription errors from manual data entry. 💡Innovative Technology: Built on cutting-edge technology, eBinder offers a secure and user-friendly platform converting scanned DCFs into digital format to EDC. 🔍 Efficient Document Management: eBinder streamlines document organization and retrieval, ensuring quick access to essential trial materials while minimizing administrative overhead. 🌐 Remote Accessibility: Whether you're across the street or across the globe, eBinder provides seamless access to trial data, fostering collaboration among researchers and stakeholders. #EarthDay #PaperlessTrials #eBinder #ClinicalResearch